{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cerclage", "Cervical insufficiency", "Pregnancy", "Probiotic"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38724897", "DateCompleted": {"Year": "2024", "Month": "05", "Day": "10"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "10"}, "Article": {"Language": ["eng"], "ELocationID": ["311", "10.1186/s12884-024-06496-x"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "09"}], "Journal": {"ISSN": "1471-2393", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2024", "Month": "May", "Day": "09"}}, "Title": "BMC pregnancy and childbirth", "ISOAbbreviation": "BMC Pregnancy Childbirth"}, "ArticleTitle": "Pregnancy outcomes in pregnant women taking oral probiotic undergoing cerclage compared to placebo: two blinded randomized controlled trial.", "Pagination": {"StartPage": "311", "MedlinePgn": "311"}, "Abstract": {"AbstractText": ["The purpose of this study is to evaluate the oral probiotic effect on pregnancy outcomes in pregnant women undergoing cerclage compared to placebo.", "This study was a double-blind randomized clinical trial undertaken in Yasuj, Iran. 114 eligible participants who have undergone cerclage were randomly divided to either receive probiotic adjuvant or 17\u03b1-OHP (250\u00a0mg, IM) with placebo from the 16th -37th week of pregnancy by \"block\" randomization method. Our primary outcomes were preterm labor (PTB) (late and early) and secondary outcomes were other obstetrical and neonatal outcomes included preterm pre-labor rupture of membranes (PPROM), pre-labor rupture of membranes (PROM), mode of delivery, and neonatal outcomes including anthropometric characterize and Apgar score (one and fifth-minute).", "Results show that there are no statistically significant differences between the two groups in terms of PTB in <\u200934th (15.51% vs. 17.86%; P\u2009=\u20090.73) and 34-37th weeks of pregnancy (8.7% vs. 16.1%; P\u2009=\u20090.22), and mode of delivery (P\u2009=\u20090.09). PPROM (8.7% vs. 28.5%; P\u2009=\u20090.006) PROM (10.3% vs. 25%; P\u2009=\u20090.04) was significantly lower in patients receiving probiotic adjuvant compared to the control group. After delivery, the findings of the present study showed that there were no significant differences in newborn's weight (3082.46\u2009\u00b1\u2009521.8vs. 2983.89\u2009\u00b1\u2009623.89), head circumstance (36.86\u2009\u00b1\u20091.53vs. 36.574\u2009\u00b1\u20091.52), height (45.4\u2009\u00b1\u20095.34 vs. 47.33\u2009\u00b1\u20094.92) and Apgar score in one (0.89\u2009\u00b1\u20090.03 vs. 0.88\u2009\u00b1\u20090.05) and five minutes (0.99\u2009\u00b1\u20090.03vs. 0.99\u2009\u00b1\u20090.03) after birth.", "Our result has shown that the consumption of Lactofem probiotic from the 16th week until 37th of pregnancy can lead to a reduction of complications such as PPROM and PROM."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Gynecologic and Obstetrics Department, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Vanda", "ForeName": "Raziyeh", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Gynecologic and Obstetrics Department, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Dastani", "ForeName": "Tahora", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Taghavi", "ForeName": "Seyed-Abdolvahab", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Sadeghi", "ForeName": "Hossein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Mental Health and Social Work, Middlesex University, London, UK."}], "LastName": "Lambert", "ForeName": "Nicky", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran. f.bazarganipour@gmail.com."}], "LastName": "Bazarganipour", "ForeName": "Fatemeh", "Initials": "F"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Pregnancy Childbirth", "NlmUniqueID": "100967799", "ISSNLinking": "1471-2393"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Pregnancy"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["therapeutic use", "administration & dosage"], "DescriptorName": "Probiotics"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Pregnancy Outcome"}, {"QualifierName": [], "DescriptorName": "Iran"}, {"QualifierName": ["methods"], "DescriptorName": "Cerclage, Cervical"}, {"QualifierName": [], "DescriptorName": "Infant, Newborn"}, {"QualifierName": [], "DescriptorName": "Fetal Membranes, Premature Rupture"}, {"QualifierName": [], "DescriptorName": "Young Adult"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Premature Birth"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Obstetric Labor, Premature"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "ACOG Practice Bulletin 142 Cerclage for the management of cervical insufficiency. Obstet Gynecol. 2014;123(2 Pt 1):372\u20139.", "ArticleIdList": ["24451674"]}, {"Citation": "Fuchs F, Senat MV, Fernandez H, Gervaise A, Frydman R, Bouyer J. Predictive score for early preterm birth in decisions about emergency cervical cerclage in singleton pregnancies. Acta Obstet Gynecol Scand. 2012;91(6):744\u20139. doi: 10.1111/j.1600-0412.2012.01386.x.", "ArticleIdList": ["10.1111/j.1600-0412.2012.01386.x", "22375688"]}, {"Citation": "Gupta M, Emary K, Impey L. Emergency cervical cerclage: predictors of success. J Matern Fetal Neonatal Med. 2010;23(7):670\u20134. doi: 10.3109/14767050903387011.", "ArticleIdList": ["10.3109/14767050903387011", "19883267"]}, {"Citation": "Shiffman RL. Continuous low-dose antibiotics and cerclage for recurrent second-trimester pregnancy loss. J Reprod Med. 2000;45(4):323\u20136.", "ArticleIdList": ["10804489"]}, {"Citation": "Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG. 2006;113(1):65\u201374. doi: 10.1111/j.1471-0528.2005.00788.x.", "ArticleIdList": ["10.1111/j.1471-0528.2005.00788.x", "16398774"]}, {"Citation": "Sieber R, Dietz U-T. Lactobacillus acidophilus and yogurt in the Prevention and Therapy of bacterial vaginosis. Int Dairy J. 1998;8(7):599\u2013607. doi: 10.1016/S0958-6946(98)00096-X.", "ArticleIdList": ["10.1016/S0958-6946(98)00096-X"]}, {"Citation": "Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol. 2003;189(4):1202\u20138. doi: 10.1067/S0002-9378(03)00495-2.", "ArticleIdList": ["10.1067/S0002-9378(03)00495-2", "14586379"]}, {"Citation": "Andreu A. Lactobacillus as a probiotic for preventing urogenital infections. Reviews Med Microbiol. 2004;15(1):1\u20136. doi: 10.1097/01.revmedmi.0000131423.90481.82.", "ArticleIdList": ["10.1097/01.revmedmi.0000131423.90481.82"]}, {"Citation": "Reid G. The development of probiotics for women\u2019s health. Can J Microbiol. 2017;63(4):269\u201377. doi: 10.1139/cjm-2016-0733.", "ArticleIdList": ["10.1139/cjm-2016-0733", "28177795"]}, {"Citation": "Grev J, Berg M, Soll R. Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Reviews. 2018(12).", "ArticleIdList": ["PMC6516999", "30548483"]}, {"Citation": "Solgi E, Tavakoli-Far B, Badehnoosh B, Khavandegar A, Bakhtiyari M. Vaginal and oral probiotics effect in the prevention of preterm delivery in patients visiting Kamali Hospital, Karaj, Iran in 2020. Eur J Obstet Gynecol Reprod Biol X. 2022;16:100169. doi: 10.1016/j.eurox.2022.100169.", "ArticleIdList": ["10.1016/j.eurox.2022.100169", "PMC9596744", "36312324"]}, {"Citation": "Jarde A, Lewis-Mikhael A-M, Moayyedi P, Stearns JC, Collins SM, Beyene J, et al. Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2018;18(1):14. doi: 10.1186/s12884-017-1629-5.", "ArticleIdList": ["10.1186/s12884-017-1629-5", "PMC5759212", "29310610"]}, {"Citation": "Baradwan S, AlSghan R, Sabban H, Khadawardi K, Abdelrahman Mohamed Ali Z, Felemban LHA, et al. Vaginal probiotics as an adjunct to antibiotic prophylaxis in the management of preterm premature rupture of membranes: a systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2023;291:112\u20139. doi: 10.1016/j.ejogrb.2023.10.011.", "ArticleIdList": ["10.1016/j.ejogrb.2023.10.011", "37862929"]}, {"Citation": "Kirihara N, Kamitomo M, Tabira T, Hashimoto T, Taniguchi H, Maeda T. Effect of probiotics on perinatal outcome in patients at high risk of preterm birth. J Obstet Gynaecol Res. 2018;44(2):241\u20137. doi: 10.1111/jog.13497.", "ArticleIdList": ["10.1111/jog.13497", "28994162"]}, {"Citation": "Badehnoosh B, Karamali M, Zarrati M, Jamilian M, Bahmani F, Tajabadi-Ebrahimi M, et al. The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes. J Matern Fetal Neonatal Med. 2018;31(9):1128\u201336. doi: 10.1080/14767058.2017.1310193.", "ArticleIdList": ["10.1080/14767058.2017.1310193", "28326881"]}, {"Citation": "Dagklis T, Tsakiridis I, Papazisis G, Athanasiadis A. Efficacy and safety of corticosteroids\u2019 Administration for Pulmonary Immaturity in Anticipated Preterm Delivery. Curr Pharm Des. 2021;27(36):3754\u201361. doi: 10.2174/1381612826666201207102910.", "ArticleIdList": ["10.2174/1381612826666201207102910", "33423644"]}, {"Citation": "Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet. 1995;346(8985):1271\u20139. doi: 10.1016/S0140-6736(95)91868-X.", "ArticleIdList": ["10.1016/S0140-6736(95)91868-X", "7475723"]}, {"Citation": "Cribby S, Taylor M, Reid G. Vaginal microbiota and the use of probiotics. Interdiscip Perspect Infect Dis. 2008;2008:256490\u2013256490. doi: 10.1155/2008/256490.", "ArticleIdList": ["10.1155/2008/256490", "PMC2662373", "19343185"]}, {"Citation": "Reid JN, Bisanz JE, Monachese M, Burton JP, Reid G. The rationale for probiotics improving reproductive health and pregnancy outcome. Am J Reprod Immunol. 2013;69(6):558\u201366. doi: 10.1111/aji.12086.", "ArticleIdList": ["10.1111/aji.12086", "23414386"]}, {"Citation": "Mastromarino P, Macchia S, Meggiorini L, Trinchieri V, Mosca L, Perluigi M, et al. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect. 2009;15(1):67\u201374. doi: 10.1111/j.1469-0691.2008.02112.x.", "ArticleIdList": ["10.1111/j.1469-0691.2008.02112.x", "19046169"]}, {"Citation": "Lee JE, Han JY, Choi JS, Ahn HK, Lee SW, Kim MH, et al. Pregnancy outcome after exposure to the probiotic Lactobacillus in early pregnancy. J Obstet Gynaecol. 2012;32(3):227\u20139. doi: 10.3109/01443615.2011.641621.", "ArticleIdList": ["10.3109/01443615.2011.641621", "22369393"]}, {"Citation": "Lindsay KL, Brennan L, Kennelly MA, Maguire OC, Smith T, Curran S, et al. Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial. Am J Obstet Gynecol. 2015;212(4):e4961\u201311. doi: 10.1016/j.ajog.2015.02.008.", "ArticleIdList": ["10.1016/j.ajog.2015.02.008", "25687568"]}, {"Citation": "Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001;32:37\u201341. doi: 10.1111/j.1574-695X.2001.tb00531.x.", "ArticleIdList": ["10.1111/j.1574-695X.2001.tb00531.x", "11750220"]}, {"Citation": "Othman M, Neilson JP, Alfirevic Z. Probiotics for preventing preterm labour. Cochrane Database Syst Rev. 2007;1:CD005941. doi: 10.1002/14651858.CD005941.pub2.", "ArticleIdList": ["10.1002/14651858.CD005941.pub2", "PMC9006117", "17253567"]}, {"Citation": "Homayouni A, Bastani P, Ziyadi S, Mohammad-Alizadeh-Charandabi S, Ghalibaf M, Mortazavian AM, et al. Effects of probiotics on the recurrence of bacterial vaginosis: a review. J Low Genit Tract Dis. 2014;18:79\u201386. doi: 10.1097/LGT.0b013e31829156ec.", "ArticleIdList": ["10.1097/LGT.0b013e31829156ec", "24299970"]}, {"Citation": "Morelli L, Zonenenschain D, Del Piano M, Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol. 2004;38(6 Suppl):S107\u201310. doi: 10.1097/01.mcg.0000128938.32835.98.", "ArticleIdList": ["10.1097/01.mcg.0000128938.32835.98", "15220672"]}, {"Citation": "Vallor AC, Antonio MA, Hawes SE, Hillier SL. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis. 2001;184(11):1431\u20136. doi: 10.1086/324445.", "ArticleIdList": ["10.1086/324445", "11709785"]}, {"Citation": "Mirmonsef P, Hotton AL, Gilbert D, Burgad D, Landay A, Weber KM, et al. Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. PLoS ONE. 2014;9(7):e102467. doi: 10.1371/journal.pone.0102467.", "ArticleIdList": ["10.1371/journal.pone.0102467", "PMC4102502", "25033265"]}, {"Citation": "Yang S, Reid G, Challis JR, Kim SO, Gloor GB, Bocking AD. Is there a role for probiotics in the prevention of preterm birth? Front Immunol. 2015;6:62. doi: 10.3389/fimmu.2015.00062.", "ArticleIdList": ["10.3389/fimmu.2015.00062", "PMC4330906", "25741339"]}, {"Citation": "Shewale RN, Sawale PD, Khhedkar CD, Singh A. Selection criteria for probiotics: review. Int J Probiotics Prebiotics. 2014;9(1):1\u20137."}, {"Citation": "Markowiak P, Slizewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9(9):1021. doi: 10.3390/nu9091021.", "ArticleIdList": ["10.3390/nu9091021", "PMC5622781", "28914794"]}]}], "History": [{"Year": "2023", "Month": "9", "Day": "9"}, {"Year": "2024", "Month": "4", "Day": "10"}, {"Year": "2024", "Month": "5", "Day": "10", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "10", "Hour": "0", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "9", "Hour": "23", "Minute": "39"}, {"Year": "2024", "Month": "5", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["38724897", "PMC11080304", "10.1186/s12884-024-06496-x", "10.1186/s12884-024-06496-x"]}}]}